See more : Taiyo Bussan Kaisha,Ltd. (9941.T) Income Statement Analysis – Financial Results
Complete financial analysis of BBS-Bioactive Bone Substitutes Oyj (BONEH.HE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BBS-Bioactive Bone Substitutes Oyj, a leading company in the Medical – Devices industry within the Healthcare sector.
- Quanergy Systems, Inc. (QNGYQ) Income Statement Analysis – Financial Results
- Allied Healthcare Products, Inc. (AHPI) Income Statement Analysis – Financial Results
- Ekansh Concepts Limited (EKANSH.BO) Income Statement Analysis – Financial Results
- Pharmasimple SA (ALPHS.PA) Income Statement Analysis – Financial Results
- BCE Inc. (BCE) Income Statement Analysis – Financial Results
BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)
About BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. The company offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. BBS-Bioactive Bone Substitutes Plc was incorporated in 1991 and is headquartered in Oulu, Finland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 105.69K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 3.62K | 29.95K | 56.95K | 83.06K | 105.69K | 128.26K | 102.00K | 90.00K | 9.00K | 0.00 |
| Gross Profit | -3.62K | -29.95K | -56.95K | -83.06K | 0.00 | -128.26K | -102.00K | -90.00K | -9.00K | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.24M | 2.79M | 2.40M | 2.48M | 1.36M | 872.13K | 1.30M | 618.62K | 569.51K | 23.58K |
| Other Expenses | 2.12M | 2.92M | 2.51M | 2.56M | 1.43M | -605.74K | 1.30M | 510.00K | 539.00K | 0.00 |
| Operating Expenses | 3.36M | 2.92M | 2.51M | 2.56M | 1.43M | -605.74K | 1.30M | 510.00K | 539.00K | 244.35K |
| Cost & Expenses | 3.37M | 2.95M | 2.57M | 2.65M | 1.54M | -477.48K | 1.40M | 600.00K | 548.00K | 244.35K |
| Interest Income | 33.41 | 39.68 | 44.01 | 2.27 | 0.27 | 1.80 | 0.00 | 0.00 | 0.00 | 69.05K |
| Interest Expense | 116.97K | 141.05K | 199.88K | 85.92K | 102.21K | 97.64K | 81.00K | 78.00K | 76.00K | 0.00 |
| Depreciation & Amortization | 217.00K | 225.20K | 231.34K | 213.99K | 225.42K | 155.00K | 138.54K | 506.43 | 161.00K | 142.43K |
| EBITDA | -3.15M | -2.73M | -2.34M | -2.43M | -1.31M | 632.47K | -4.23M | -599.87K | -387.00K | -101.91K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,239.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -3.37M | -2.95M | -2.57M | -2.65M | -1.54M | 477.48K | -4.35M | -600.00K | -550.00K | -244.35K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,453.28% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -116.94K | -141.01K | -199.84K | -85.91K | -102.21K | -97.64K | -102.49K | -78.00K | -76.00K | -69.05K |
| Income Before Tax | -3.48M | -3.09M | -2.77M | -2.73M | -1.64M | 379.84K | -4.43M | -678.00K | -626.00K | -313.39K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,549.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 3.00 | 141.01K | 200.22K | 85.92K | 102.63K | 1.80 | 2.00K | 107.49K | -2.00K | 0.00 |
| Net Income | -3.48M | -3.23M | -2.97M | -2.82M | -1.74M | 379.84K | -4.43M | -678.00K | -626.00K | -313.39K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,647.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.29 | -0.33 | -0.35 | -0.37 | -0.24 | 0.06 | -0.64 | -0.10 | -0.09 | -0.05 |
| EPS Diluted | -0.29 | -0.33 | -0.35 | -0.37 | -0.24 | 0.06 | -0.64 | -0.10 | -0.09 | -0.05 |
| Weighted Avg Shares Out | 12.09M | 9.82M | 8.46M | 7.55M | 7.29M | 6.03M | 4.68M | 6.87M | 6.87M | 6.87M |
| Weighted Avg Shares Out (Dil) | 12.09M | 9.82M | 8.46M | 7.55M | 7.29M | 6.03M | 4.68M | 6.87M | 6.87M | 6.87M |
Source: https://incomestatements.info
Category: Stock Reports